AstraZeneca sells more Seroquel rights to Cheplapharm for $42 million

Cheplapharm now adds the rights in United States and Canada to its recently acquired ones for Seroquel and Seroquel XR in most European markets and Russia.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news